The 800-mg Darunavir Tablet Arrives, and Scoring the Top Protease Inhibitors
Now that atazanavir and darunavir can both be dosed as one pill once daily, which is the better choice for first-line antiretroviral therapy? Take our poll at HIV and ID Observations.
The FDA recently approved an 800-mg tablet of darunavir for treatment-naive patients, which means that atazanavir and darunavir now have the same pill burden (one pill once daily). In his blog HIV and ID Observations, Dr. Paul Sax does a point-by-point comparison of darunavir and atazanavir — which is the better first choice? Take our poll here.
Published in Journal Watch HIV/AIDS Clinical Care November 19, 2012
To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.